Different Levels of Blood Flow Restriction Versus Moderate Intensity Exercises in Patients With Knee Osteoarthritis
Blood Flow Restriction With Different Loads Versus Moderate Resistive Exercises in Patients With Knee Osteoarthritis: A Double Blinded Randomized Controlled Trial
1 other identifier
interventional
75
1 country
1
Brief Summary
This clinical trail will be conducted to investigate the effect of blood flow restriction (BFR) with different load levels between low blood occlusion percentage (50%) group and high blood occlusion percentage (70%) compared to moderate intensity training (60% of 1 RM) in patients with chronic knee osteoarthritis. The main questions it aims to answer are:
- 1.Will there be no difference between the effect of (70% vs 50%) of BFR versus traditional moderate resistive training exercises on pain intensity in knee osteoarthritis ?
- 2.Will there be no difference between the effect of (70% vs 50%) of BFR versus traditional moderate resistive training exercises on quadriceps muscle strength in knee osteoarthritis ?
- 3.Will there be no difference difference between the effect of (70% vs 50%) of BFR versus traditional moderate resistive training exercises on rate of perceived exertion in knee osteoarthritis ?
- 4.Will there be no difference between the effect of (70% vs 50%) of BFR versus traditional moderate resistive training exercises on functional ability in knee osteoarthritis ?
- 5.Will there be no difference between the effect of (70% vs 50%) of BFR versus traditional moderate resistive training exercises on physical function in knee osteoarthritis ?
- 6.16 sessions of supervised intervention 2 times per week for 8 weeks.
- 7.The assessment will be at 3 time points, baseline and at 4 weeks and at 8 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable knee-osteoarthritis
Started Oct 2024
Typical duration for not_applicable knee-osteoarthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 24, 2024
CompletedFirst Posted
Study publicly available on registry
October 15, 2024
CompletedStudy Start
First participant enrolled
October 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 26, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 6, 2026
CompletedMay 6, 2026
September 1, 2025
4 months
September 24, 2024
May 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in pain intensity
Measured by the Visual Analog Scale (VAS)which is a pain intensity assessment tool. * Represented with a 10 cm line with 0 indicating no pain and on the other end 10 indicating severe pain. * The patient is asked to move a marker on the line to the position which best describes their pain. * That it will serve as a subjective measure of their current level of knee pain intensity. The closer the mark to zero is better.
Measured 3 times at basline, 4 weeks and 8 weeks
Measure change in quadriceps muscle strength
Hand-held dynamometer (HHD) will be used to measure the strength in quadriceps muscle. * The maximum force or pressure exerted by the quadriceps muscle during the contraction will be recorded. * Typically, this measurement is expressed in kilograms (kg) and then transferred to Newtons (N) * To enhance reliability, 3 trials may be conducted, and average will be taken to obtain a more representative measurement of muscle strength. * The higher the measurement the higher the muscle strength.
Measured 3 times at baseline, 4 weeks and 8 weeks
Secondary Outcomes (3)
Change in functional ability
Measured 3 times at baseline, 4 weeks and 8 weeks
Change in physical function levels
Measured 3 times at baseline, 4 weeks and 8 weeks
Change in Rate of perceived exertion scale (RPE)
Measured 3 times at basline , 4 weeks and 8 weeks
Study Arms (3)
50% Blood Flow Restriction Group
EXPERIMENTALThe Blood Flow Restriction device will be set to restrict blood flow at level of 50% of arterial occlusion pressure at rest. Blood Flow Restriction sessions will be 5 sets of 5 mins of occlusion and 3 mins of free flow , 2 sessions per week for eight weeks exercises to assess its effects on knee osteoarthritis-related outcomes.
70% Blood Flow Restriction Group
EXPERIMENTALThe Blood Flow Restriction device will be set to restrict blood flow at level of 70% of arterial occlusion pressure at rest. Blood Flow Restriction sessions will be 5 sets of 5 mins of occlusion and 3 mins of free flow , 2 sessions per week for eight weeks exercises to assess its effects on knee osteoarthritis-related outcomes.
Moderate Intensity Exercise training Group
ACTIVE COMPARATORPatients assigned to this group will receive strengthening of the lower limb musculature through moderate intensity resistance training (60% of 1RM) for a total of 16 treatment sessions according to exercise guidelines for seniors with OA. MIRT protocols consists of 3 sets for every exercise, 12 repetitions per set, rest period between sets 2 mins, 2 session per week for 8 weeks. Resistance exercises will be performed using a 45° leg-press machine, 90°-0° of knee flexion knee extension machine, leg curl machine and calf raise machine.
Interventions
Blood Flow Restriction (BFR) therapy involves units use standardized cuffs of varying widths and lengths which are physically attached to the devices and provide the capability of precisely controlling the amount of pressure applied to each limb during exercise or at rest. We will be using Smart Cuffs® 4.0 which allows for a fast, hassle-free personalized pressure calculation. With the built-in pressure sensor and on-board computer, it will calculate and set the optimal pressure for each participant's limb. There is no need for an external doppler probe or hand pump. Made in the USA, SmartCuffs® are registered with the FDA as a Class 1 Medical Device. Blood flow restriction therapy is commonly paired with resistive training, so this study will explore the effect of blood flow restriction at rest for patients with osteoarthritis at different restriction levels (50% for first group and 70% for second group).
Patients assigned to group will receive strengthening of the lower limb musculature through moderate intensity resistance training (60% of 1RM) using a 45° leg-press machine, 90°-0° of knee flexion knee extension machine, leg curl machine and calf raise machine.
Eligibility Criteria
You may qualify if:
- Patients diagnosed with chronic knee osteoarthritis referred by orthopedic surgeons participants of both genders age are 40-65.
- Patients with grade 2 and 3 OA of the knee, according to radiologic evaluation
- If both knees diagnosed as OA, the most affected one will be selected.
- Diagnosis of Knee OA who had knee pain and functional disabilities for at least three months, according to American College of Rheumatology classification at screening visit.
- Visual Analogue Scale (VAS) at rest score of ≥40 mm.
- Arabic version of the western WOMAC (ArWOMAC) scores (average 37).
- Moderate Physical activity score on the IPAQ (between 3.0 and 7.9 METS).
You may not qualify if:
- Moderate to significant knee synovitis
- Hot or red knee
- History and/or physical examination findings compatible with the internal derangement of knee.
- Knee pain that is initiated or increased with knee activity/exercise and finished or decreased with knee resting.
- Other muscular, articular, or neurological condition affecting lower limb function.
- Patients with any previous knee surgeries or fractures of lower limb
- Patients who had undergone arthroscopy or treatment with intra-articular hyaluronic acid during the previous 6 months.
- Psychological or psychiatric disorders that may affect a subject's participation in the study.
- Participants with congenital musculoskeletal lower limb deformity.
- Participated in other intervention studies on the past 6 months to screening
- Participants with contraindications to blood flow Restriction Training.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
CairoU
Cairo, Giza Governorate, 12611, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Lecturer
Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Masters Degree Student in Faculty of Physical Therapy, Cairo University
Study Record Dates
First Submitted
September 24, 2024
First Posted
October 15, 2024
Study Start
October 15, 2024
Primary Completion
February 26, 2025
Study Completion
May 6, 2026
Last Updated
May 6, 2026
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
* The risk that sharing prevents the exploitation of the entire potential of the data obtained. * Possible failures in patients' privacy protection. * Technical barriers such as the lack of standard formats and possible data misinterpretation. * Issues regarding data ownership. * Reuse of data for unfair commercial purposes.